Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia position statement.

Literature DB >> 33729207

International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia position statement.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Analgesics
Cannabinoids

Year: 2021 PMID： 33729207 DOI： 10.1097/j.pain.0000000000002265

Source DB: PubMed Journal: Pain ISSN： 0304-3959 Impact factor: 6.961

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

1. Priorities for Medical Marijuana Research from the Perspective of Physicians, Dispensary Owners/Staff, and Patients: A Survey Study.

Authors: Jennifer Jean-Jacques; Robert Cook; Almut G Winterstein; Amie Goodin; Joshua D Brown; Sebastian Jugl; Yan Wang
Journal: Med Cannabis Cannabinoids Date: 2021-08-02

2. The cannabinoid agonist CB-13 produces peripherally mediated analgesia in mice but elicits tolerance and signs of central nervous system activity with repeated dosing.

Authors: Richard A Slivicki; Jiwon Yi; Victoria E Brings; Phuong Nhu Huynh; Robert W Gereau
Journal: Pain Date: 2021-12-27 Impact factor: 7.926

3. Prevalence of cannabis use for pain management in Quebec: A post-legalization estimate among generations living with chronic pain.

Authors: Marimée Godbout-Parent; Hermine Lore Nguena Nguefack; Adriana Angarita-Fonseca; Claudie Audet; Andréanne Bernier; Ghita Zahlan; Nancy Julien; M Gabrielle Pagé; Line Guénette; Lucie Blais; Anaïs Lacasse
Journal: Can J Pain Date: 2022-06-03

International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia position statement.

1. Priorities for Medical Marijuana Research from the Perspective of Physicians, Dispensary Owners/Staff, and Patients: A Survey Study.

2. The cannabinoid agonist CB-13 produces peripherally mediated analgesia in mice but elicits tolerance and signs of central nervous system activity with repeated dosing.

3. Prevalence of cannabis use for pain management in Quebec: A post-legalization estimate among generations living with chronic pain.

Review 4. Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment.

5. Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot.

Review 6. Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation.